InChI=1S/C33H38N6O10/c1- 4- 11- 35- 30(46) 25- 27(43) 33(49) 19- 8- 6- 7- 17(24(19) 39- 32(33) 48) 18- 12- 16(9- 10- 22(18) 40) 13- 20(37- 31(47) 26(42) 15(3) 5- 2) 28(44) 36- 21(14- 23(34) 41) 29(45) 38- 25/h4,6- 12,15,20- 21,25,27,40,43,49H,5,13- 14H2,1- 3H3,(H2,34,41) (H,35,46) (H,36,44) (H,37,47) (H,38,45) (H,39,48) /b11- 4- /t15- ,20- ,21- ,25- ,27+,33- /m0/s1 |
ZIAXNZCTODBCKW-BOYGTWLISA-N |
CC[C@H] (C) C(=O) C(=O) N[C@H] 1Cc2ccc(O) c(c2) - c2cccc3c2NC(=O) [C@@] 3(O) [C@H] (O) [C@H] (NC(=O) [C@H] (CC(N) =O) NC1=O) C(=O) N\C=C/C |
|
Apiospora montagnei
(NCBI:txid255776)
|
of strain
TC 1093
See:
PubMed
|
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
fungal metabolite
Any eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
|
|
proteasome inhibitor
A drug that blocks the action of proteasomes, cellular complexes that break down proteins.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(10S,11R,12S,15S,18S)- 15- (2- amino- 2- oxoethyl)- 10,11,23- trihydroxy- 18- {[(3S)- 3- methyl- 2- oxopentanoyl]amino}- 9,14,17- trioxo- N- [(1Z)- prop- 1- en- 1- yl]- 8,13,16- triazatetracyclo[18.3.1.02,7.06,10]tetracosa- 1(24),2,4,6,20,22- hexaene- 12- carboxamide
|
9110474
|
Reaxys Registry Number
|
Reaxys
|
10814045
|
PubMed citation
|
Europe PMC
|
|